Patent details

EP3790542 Title: COMBINATION THERAPY FOR TREATMENT OF HCV

Basic Information

Publication number:
EP3790542
PCT Application Number:
US2019031459
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP197262595
PCT Publication Number:
WO2019217643
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION THERAPY FOR TREATMENT OF HCV
French Title of Invention:
POLYTHÉRAPIE POUR LE TRAITEMENT DU VIRUS DE L'HÉPATITE C
German Title of Invention:
KOMBINATIONSTHERAPIE ZUR BEHANDLUNG VON HCV
SPC Number:

Dates

Filing date:
09/05/2019
Grant date:
19/07/2023
EP Publication Date:
17/03/2021
PCT Publication Date:
14/11/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/07/2023
EP B1 Publication Date:
19/07/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/05/2024
Expiration date:
09/05/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/07/2023
 
 

Name:
Cocrystal Pharma, Inc.
Address:
19805 North Creek Parkway, Bothell, WA 98011, United States (US)

Inventor

1

Name:
LEE, Sam, SK
Address:
United States (US)

2

Name:
LIN, Biing, Yuan
Address:
United States (US)

3

Name:
JACOBSON, Irina, C.
Address:
United States (US)

Priority

Priority Number:
201862669007 P
Priority Date:
09/05/2018
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/343; A61K 45/06; A61K 31/4178; A61K 31/4188; A61K 31/439; A61K 31/454; A61K 31/4725; A61K 31/498; A61K 31/7056; A61K 31/7068; A61K 31/7072; A61P 31/14;

Publication

European Patent Bulletin

Issue number:
202329
Publication date:
19/07/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages